CASBF
CANSINO BIOLGICS REG H by CANSINO BIOLOGICS INC (CASBF)
$20
About CANSINO BIOLGICS REG H by CANSINO BIOLOGICS INC (CASBF)
CanSino Biologics, Inc. engages in the research and development, manufacturing, and sale of vaccines. It offers shingles, meningitis, polio, adenovirus, and tuberculosis vaccines. The company was founded by Xuan Liu, Xue Feng Yu, Tao Zhu, Dong Xu Qiu and Hui Hua Mao on January 13, 2009 and is headquartered in Tianjin, China.
Details
Daily high
--
Daily low
--
Price at open
--
52 Week High
$4.90
52 Week Low
$1.98
Market cap
791.5M
Dividend yield
0.00%
Volume
--
Avg. volume
3,666
P/E ratio
-15.03
CANSINO BIOLGICS REG H by CANSINO BIOLOGICS INC News
Details
Daily high
--
Daily low
--
Price at open
--
52 Week High
$4.90
52 Week Low
$1.98
Market cap
791.5M
Dividend yield
0.00%
Volume
--
Avg. volume
3,666
P/E ratio
-15.03